Abstract:Background Spinal Muscular Atrophy (SMA) is a progressive degenerative neuromuscular disease that can cause several motor, respiratory, and functional impairments, directly interfering with the quality of life (QoL). Depending on the severity of the SMA, the individual may need intermittent care and their caregivers may feel overwhelmed with this responsibility. Objectives To correlate caregiver burden and motor function measurement (MFM) of individuals with SMA with their QoL. Methods Descriptive cross-sectional study, carried out in a state rehabilitation center in Goiânia, Goiás, Brazil. Data collection was carried out from March to July 2022, consisting of individuals diagnosed with SMA types I, II, and III being followed up at the institution's Neuromuscular Diseases Clinic and their main family caregivers. To analyze the MFM, participants younger than six years old were evaluated using the Motor Function Measurement Scale - Short Version (MFM-20), and those older than six years old using the Motor Function Measurement Scale (MFM-32). For QoL assessment, those over five years old answered the PedsQL Neuromuscular 3.0 questionnaire according to age group, while those under five years old had the same questionnaire answered by their guardians. To assess caregiver burden, the Burden Interview questionnaire was used. The distribution of demographic profile and clinical data was tested according to the type of SMA by applying Pearson's Chi-square test and “Post hoc” standardized residual analysis. The QoL, MFM, and caregiver burden were tested between the types of EBF using the Analysis of Covariance (ANCOVA), controlling the effect of variables that presented p < 0.05 in the initial exploratory analyses. The significance level adopted was p < 0.05. Results The sample consisted of 32 individuals with SMA, 6(18.7%) type I, 9(28.1%) type II, and 17(53.1%) type III, with a mean age of 21.9± 17.3 years old, mostly male 17(53.1%) and 27 caregivers, 26(96.3%) females. The MFM showed a moderate positive correlation with the QoL of individuals with SMA type II (r = 0.71; p = 0.05) and in type III it had a strong positive correlation with statistical significance (r = 0.63; p = 0. 01). Caregiver burden had a negative correlation with QoL in SMA types II and III (r = - 0.71; p = 0.05 and r = -0.16; p = 0.63, respectively), without statistical significance. Conclusion MFM correlated with the QoL of individuals with SMA, especially type III. The burden of caregivers showed a negative relationship with the QoL of people with SMA, highlighting the need for care for this population. Implications Knowledge of the motor function of individuals with SMA and the burden of their caregivers are important aspects that allow for more specific therapeutic approaches according to their individualities.

Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany

Quality of Life of Children with Spinal Muscular Atrophy and Their Caregivers from the Perspective of Caregivers: a Chinese Cross-Sectional Study

Quality of Life Assessment in Romanian Patients with Spinal Muscular Atrophy Undergoing Nusinersen Treatment

Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy

Parents as informal caregivers of children and adolescents with spinal muscular atrophy: a systematic review of quantitative and qualitative data on the psychosocial situation, caregiver burden, and family needs

Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report

Management and current status of spinal muscular atrophy: a retrospective multicentre claims database analysis

Assessing Perspectives of Disease Burden and Clinically Meaningful Changes Using the Spinal Muscular Atrophy Health Index in Adolescents and Young Adults

Factors Influencing Health-Related Quality of Life of Patients with Spinocerebellar Ataxia

Measuring quality of life in children with spinal muscular atrophy: a systematic literature review

A Query to the Spinal Muscular Atrophy Registry

Disability and quality of life in individuals with muscular dystrophy

Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability

Identification of the most relevant aspects of spinal muscular atrophy (SMA) with impact on the quality of life of SMA patients and their caregivers: the PROfuture project, a qualitative study

RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy

[Pregnancy in pulmonary arterial hypertension patients].

IMPACT OF MOTOR FUNCTION OF INDIVIDUALS WITH SPINAL MUSCULAR AMYOTROPHY AND OVERLOAD OF THEIR CAREGIVERS ON QUALITY OF LIFE

Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability (P5-4.003)

Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.

Clinicogenetic characterization and response to disease-modifying therapies in spinal muscular atrophy: real-world experience from a reference center in Southern Brazil

Healthcare resource utilization of spinal muscular atrophy in the Brazilian Unified Health System: a retrospective database study